Dept of Gastroenterology, Ospedale Santa Chiara, APSS, Trento, Italy.
Dept of Epidemiology and Biostatistics, APSS, Trento, Italy.
Dig Liver Dis. 2018 May;50(5):475-481. doi: 10.1016/j.dld.2018.02.007. Epub 2018 Feb 21.
There are few prospective data about the use of surveillance colonoscopy and the risk of recurrent neoplasia in first degree relatives (FDRs) of colorectal cancer (CRC) patients. We examined the use and yield of surveillance colonoscopy in a population-based screening program (Trentino, Italy) METHODS: 1252 FDRs have been included in this study. We calculated compliance (percentage of FDRs who underwent surveillance colonoscopy among those eligible), appropriateness of colonoscopy (appropriate if performed within 6 months of the guidelines recommended interval) and diagnostic yield for neoplasia. We compared these data with those of 765 individuals without a family history (FH) of CRC who underwent screening colonoscopy in the same period (controls).
Compliance and appropriateness were higher in FDRs than in controls (93.0% vs. 48.0%; p < 0.001; 59.6% vs. 18.8%; p < 0.0001, respectively). Younger age, female sex, FH of CRC and both non-advanced adenomas (nAA) and advanced adenomas (AA) at screening colonoscopy were predictors of appropriate surveillance. The cumulative incidence of nAA and AA was similar in FDRs and controls (31.7% and 4.9% in FDRs, including three invasive cancers; 32.4% and 5.8% in controls, respectively).
FH does not increase the risk of AA in a 5-year follow-up; appropriate surveillance practices in FDRs could be highly expected in an organized screening program.
关于结直肠癌(CRC)患者一级亲属(FDRs)使用监测性结肠镜检查以及复发性肿瘤风险的前瞻性数据较少。我们在一个基于人群的筛查计划(意大利特伦蒂诺)中检查了监测性结肠镜检查的使用情况和效果。
本研究纳入了 1252 名 FDRs。我们计算了结肠镜检查的依从性(在符合条件的 FDRs 中进行监测性结肠镜检查的比例)、结肠镜检查的适当性(如果在指南推荐的间隔期内 6 个月内进行,则为适当)和肿瘤的诊断效果。我们将这些数据与同期接受筛查性结肠镜检查且无 CRC 家族史(FH)的 765 名个体(对照组)的数据进行了比较。
FDRs 的依从性和适当性均高于对照组(93.0% vs. 48.0%;p<0.001;59.6% vs. 18.8%;p<0.0001)。年龄较小、女性、CRC FH 以及筛查性结肠镜检查时同时存在非高级别腺瘤(nAA)和高级别腺瘤(AA),是适当监测的预测因素。FDRs 和对照组的 nAA 和 AA 累积发生率相似(FDRs 中为 31.7%和 4.9%,包括 3 例浸润性癌;对照组中为 32.4%和 5.8%)。
在 5 年随访中,FH 并不会增加 AA 的风险;在有组织的筛查计划中,FDRs 中适当的监测实践是可以高度预期的。